Hindustan Zinc Q2 Profit Jumps to Rs 6,412 Crore; Revenue Surges

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Hindustan Zinc Q2 Profit Jumps to Rs 6,412 Crore; Revenue Surges

Hindustan Zinc reported a stellar performance for the quarter ended September 30, 2026, with consolidated net profit soaring to Rs 6,412 crore from Rs 2,649 crore in the year-ago period. Revenue climbed to Rs 15,093 crore. While operational metrics look strong, the company continues to address ongoing regulatory inquiries.

Hindustan Zinc Q2 FY27: Net Profit More Than Doubles to Rs 6,412 Crore

Revenue stands at Rs 15,093 crore; Earnings Per Share rises to Rs 15.18.

Reader Takeaway: Strong operational growth and expanded margins are driving performance, though investors should monitor ongoing regulatory cooperation.

What just happened

Hindustan Zinc has declared its financial results for the quarter ending September 30, 2026. The company recorded a consolidated revenue of Rs 15,093 crore, a significant jump from the Rs 8,549 crore reported in the same quarter last year. Consolidated net profit reached Rs 6,412 crore, compared to Rs 2,649 crore a year earlier.

Why this matters

The sharp rise in profitability is underpinned by improved operational efficiencies and strong top-line growth. Earnings Per Share (EPS) for the quarter stood at Rs 15.18, up from Rs 6.27 in the previous year. This performance highlights the company's ability to capitalize on market conditions effectively.

Governance and Regulatory Update

The filing addresses ongoing regulatory matters, including observations from SEBI and investigations by the Enforcement Directorate. The company maintains that its transactions possess commercial substance and were approved via standard processes. Management stated that they are cooperating fully with authorities and have provided all requested information and records.

What to track next

Investors should focus on the company's ability to maintain these elevated margins in the coming quarters. Furthermore, the progression of the ongoing regulatory discussions remains a key item to watch as the company moves through the remainder of the fiscal year.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.